Nutritional Science Funding Opportunities
| Title | Announcement # |
Expiration Date |
|---|---|---|
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression ( | PA-18-739 (R21 Clinical Trial Optional) | 05/08/2021 |
| Exploratory/Developmental Clinical Research Grants in Obesity | PA-18-720 (R21 Clinical Trial Optional) | 05/08/2021 |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression | PA-18-738 (R01 Clinical Trial Optional) | 05/08/2021 |
| Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) | PAR-20-133 | 06/09/2021 |
| Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) | PAR-20-134 | 06/09/2021 |
| Diet and Physical Activity Assessment Methodology | PA-18-856 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-893 (R01 Clinical Trial Optional) | 09/08/2021 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-892 (R21 Clinical Trial Optional) | 09/08/2021 |
| Diet and Physical Activity Assessment Methodology | PAR-18-857 (R21 Clinical Trial Not Allowed) | 09/08/2021 |
| Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research | PA-18-876 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-199 (R21 Clinical Trial Not Allowed) | 11/09/2021 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-198 (R01 Clinical Trial Not Allowed) | 11/09/2021 |